Westfield Capital Management
SRPT icon

Westfield Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Westfield Capital Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-806,400
Closed -$97.8M – 263
2023
Q3 		$97.8M Buy
806,400
+230,618
+40% +$26.1M 0.67% 40
2023
Q2 		$65.9M Sell
575,782
-226,876
-28% -$29.3M 0.42% 94
2023
Q1 		$111M Buy
802,658
+50,962
+7% +$6.61M 0.78% 32
2022
Q4 		$97.4M Buy
751,696
+156,880
+26% +$18.2M 0.75% 38
2022
Q3 		$65.8M Buy
+594,816
New +$60M 0.52% 65
2021
Q1 		– Sell
-279,328
Closed -$47.6M – 280
2020
Q4 		$47.6M Sell
279,328
-62,827
-18% -$9.31M 0.28% 123
2020
Q3 		$48M Buy
342,155
+40,010
+13% +$6.08M 0.31% 105
2020
Q2 		$48.4M Sell
302,145
-43,941
-13% -$5.98M 0.33% 101
2020
Q1 		$33.9M Buy
346,086
+19,808
+6% +$2.26M 0.3% 103
2019
Q4 		$42.1M Buy
326,278
+5,717
+2% +$577K 0.3% 115
2019
Q3 		$24.1M Buy
320,561
+46,704
+17% +$5.52M 0.19% 141
2019
Q2 		$41.6M Sell
273,857
-17,630
-6% -$2.14M 0.31% 113
2019
Q1 		$34.7M Buy
291,487
+36,385
+14% +$4.68M 0.26% 126
2018
Q4 		$27.8M Buy
255,102
+160,447
+170% +$20.1M 0.24% 131
2018
Q3 		$15.3M Buy
+94,655
New +$12.9M 0.11% 188

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Westfield Capital Management's SRPT Position: Q4 2023 in Review

Westfield Capital Management sold out of Sarepta Therapeutics (SRPT) in Q4 2023, closing a stake of 806,400 shares — an estimated $97.8M sold.

Westfield Capital Management first reported a position in SRPT in Q3 2018 and held it in 15 quarters. The position peaked at $111M in Q1 2023. 395 funds tracked by Wall St. Rank hold SRPT as of Q4 2023.

  • Westfield Capital Management reported no remaining Sarepta Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Westfield Capital Management sold 806,400 Sarepta Therapeutics shares in Q4 2023, an estimated $97.8M.
  • Westfield Capital Management first reported a position in Sarepta Therapeutics in Q3 2018 and held it in 15 quarters.
  • Westfield Capital Management's Sarepta Therapeutics position peaked at $111M in Q1 2023.
  • 395 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2023.

Based on Westfield Capital Management's 13F filing for Q4 2023, filed 9 Feb 2024.